Paramount Skydance (PSKY): Assessing Valuation After Recent Share Price Momentum

Paramount Skydance (PSKY) stock has been on investors’ radar lately, especially after recent market movements. While there has not been a headline-grabbing event, its monthly return and yearly performance create an interesting setup to watch.

See our latest analysis for Paramount Skydance.

Paramount Skydance’s share price has seen sharp shifts lately. A 49% gain over the past quarter signals momentum is building, even as its one-year total shareholder return stands at a solid 39%. This combination of strong recent price movement and longer-term challenges has investors watching for signs of continued growth or renewed volatility ahead.

If you’re keen to catch the next set of market movers, now is an ideal time to widen your lens and discover fast growing stocks with high insider ownership

With shares rebounding sharply yet trading near analyst targets, Paramount Skydance’s recent gains raise a crucial question for investors: Is PSKY undervalued based on its fundamentals, or is future growth already reflected in the price?

Advertisement

Price-to-Sales Ratio of 0.6x: Is it justified?

Paramount Skydance’s current price-to-sales ratio sits at 0.6x, much lower than its peer average. With the last close price at $15.10, the stock is trading at a significant discount when valued on revenue, suggesting investors may be overlooking something.

The price-to-sales ratio measures how much investors are willing to pay per dollar of revenue earned. For a media business like PSKY, which is still on the path to profitability but has sizable revenues, this metric can signal perceived future growth or caution about earnings quality.

At 0.6x, PSKY’s multiple is not just below the peer average of 2.6x, but also lower than the US Media industry average of 1.1x. The market is currently valuing each dollar of PSKY’s revenue at a deep discount, considerably below what similar companies command. Additionally, compared to its estimated fair price-to-sales ratio of 1.7x, there is room for upward re-rating if PSKY can deliver on future performance.

Explore the SWS fair ratio for Paramount Skydance

Result: Price-to-Sales Ratio of 0.6x (UNDERVALUED)

However, soft annual revenue growth of just under 4 percent and continued net losses could temper optimism and lead to renewed investor caution.

Find out about the key risks to this Paramount Skydance narrative.

Another View: SWS DCF Model Weighs In

Looking at Paramount Skydance through our DCF model offers a very different perspective. The SWS DCF model estimates a fair value of $57.62 compared to the current price of $15.10. This suggests that the stock is deeply undervalued on a cash flow basis. Could the real opportunity lie beneath the surface?

Look into how the SWS DCF model arrives at its fair value.

PSKY Discounted Cash Flow as at Nov 2025
PSKY Discounted Cash Flow as at Nov 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Paramount Skydance for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 876 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Paramount Skydance Narrative

If you would rather rely on your own research or have a different take on the numbers, you can craft a narrative yourself in just a few minutes, so why not Do it your way

A great starting point for your Paramount Skydance research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Don't let a single opportunity set your limits. Right now, you could be positioning yourself ahead of the next wave by checking out unique stocks shaking up the market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:PSKY

Paramount Skydance

Operates as a media and entertainment company worldwide.

Undervalued with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
85 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
193 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0